Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

PHAGO

Neuronet convenes 6th meeting of its Scientific Coordination Board

3rd March 202222nd March 2021
Neuronet Scientific Coordination Board meeting 22032021

On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened

Neuronet Working Group on sustainability holds an online meeting, sharing sustainability plans among projects

15th October 202125th January 2021
Sustainability Working GroupPicture2

On 25 January, Neuronet hosted an online meeting of its WG on Sustainability, moderated by

Fraunhofer SCAI launches a new COVID-19 knowledge space, building on tools developed during the AETIONOMY & PHAGO projects

4th November 202030th April 2020
Fraunhofer SCAI launches a new COVID-19 knowledge space, building on tools developed during the AETIONOMY & PHAGO projects 800x535

On 23 April, Fraunhofer SCAI launched a new COVID-19 knowledge space which hosts tools for

New perspectives in Alzheimer’s research – Scalable culturing technique for stem cell models developed

4th November 202029th April 2020

LIFE & BRAIN GmbH, a SME based in Bonn, Germany, and partner within the PHAGO

PHAGO project holds 4th General Assembly Meeting in Erl Wood

22nd October 20201st November 2019
PHAGO MEETING OCT 19, Inflammation and Alzheimer's disease: modulating microglia function - focussing on TREM2 and CD33

With the PHAGO (Inflammation and Alzheimer’s disease: modulating microglia function – focussing on TREM2 and

Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond

14th January 202225th October 2019
Neuronet annual event parallel session, José Luis Molinuevo AMYPAD; Craig Ritchie, EPAD; Mercè B oada MOPEAD; Dag Aarsland, RADAR-AD

Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together

Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague

14th January 202223rd October 2019
Neuronet Scientific Coordination Board meeting The Hague Alzheimer Europe

On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second

Neuronet campaign launches on social media – Why we do what we do

5th February 202013th September 2019
Neuronet projects, IMPRiND, ROADMAP, PRISM, EMIF, EPAD, MOPEAD, ADAPTED, RADAR-CNS, EQIPD, AMYPAD, PHAGO, RADAR-AD, AETIONOMY, IM2PACT, PD-MitoQUANT

Neuronet’s communication team and our community of communication representatives are pleased to announce that we will celebrate our projects.

Neuronet Scientific Coordination Board meeting brings together project leaders

3rd December 20217th July 2019
Scientific Coordination Board, Carlos Diaz, Hugh Marston, George Tofaris, Mercè Boada, Pieter Jelle Visser, Darrel Pemberton, Craig Ritchie, Andreas Ebneth, Malcolm Macleod, Margot Bakker

Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.

PHAGO reveals complex role of TREM2 gene in Alzheimer’s disease

13th June 20228th January 2019

Scientists have shed new light on how a gene called TREM2 influences the progression of Alzheimer’s disease in different ways in the early and later stages.

Post navigation
Newer posts
← Previous Page1 Page2

LATEST NEWS

  • Watch interviews with RADAR-CNS researchers and members of its Patient Advisory Board

    8th August 2022
    RADAR-CNS was a Innovative Medicines Initiative (IMI) funded collaborative research project that explored the potentialRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    1st August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • AMYPAD announces Last Patient Out in its Prognostic Study

    15th July 2022
    On the 30 June, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD)Read More
  • AAIC workshop on fluid biomarkers features EPND partners, Charlotte Teunissen and Henrik Zetterberg

    8th July 2022
    The Alzheimer’s Association International Conference (AAIC), organised annually by the US Alzheimer’s Association, is knownRead More
  • PD-MitoQUANT holds Final Project Meeting in Copenhagen

    7th July 2022
    Time has certainly flown! With the PD-MitoQUANT project formally ending in July 2022, project partnersRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2022 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT